Endothermic steam and antibacterial skin anesthetic and its application device
The syringe attachment system addresses pain and infection risks in injections by converting liquefied endothermic gas to vapor for rapid numbing and antibacterial action, enhancing injection precision and safety.
Patent Information
- Application Number
- JP2024553155
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-11-29
- Filing Date
- 2022-11-29
- Publication Date
- 2024-11-15
AI Technical Summary
Conventional injection techniques cause pain and potential infection due to inadequate numbing and hygiene issues, with existing numbing agents failing to effectively reduce pain and prevent microbial entry.
A syringe attachment system that converts liquefied endothermic gas into vapor for rapid skin cooling and numbing, combined with an antibacterial agent, to minimize pain and infection risk.
The system provides effective pain relief and infection prevention by rapidly numbing the skin, ensuring precise injection site identification and reducing the need for repositioning during use.
Smart Images

Figure 2024542872000001_ABST
Abstract
Description
[Technical field]
[0001] Generally, the present invention relates to an apparatus for applying endothermic gas to tissue to anesthetically administer an injection site prior to injection to minimize pain associated with conventional injection techniques. In particular, the apparatus includes a container of liquefied endothermic gas and a system for converting the liquefied endothermic gas to vapor for application to the skin. [Background technology]
[0002] Syringes are used millions of times daily around the world to inject medications into humans and animals. In many cases, the injection is given in a part of the body that is not very sensitive to pain. Other parts of the body where the injection is scheduled are quite sensitive to pain and when the needle is inserted under the skin, the patient feels a pinching sensation and can be very painful. Such parts include, for example, the gums, the forehead in facial areas such as the forehead, and the lips. To minimize the pain caused when the needle penetrates the patient's gums etc., dental practitioners often use cotton swabs to apply a topical agent to the injection site. Numbing agents are only applied topically and do not pass through the skin / mucosa, so they are ineffective and give the patient a false expectation of a painless injection. As a result, injections of anesthetic agents often cause considerable pain at the injection site. In other cases, such as diabetic patients, the patient may have to self-medicate daily. Repeated injections often create sensitive areas where the injection is painful for the patient. This pain may cause the patient to delay or skip dosing to avoid the associated pain. Current devices that use cold spray to numb the injection site, even those by the present inventor, suffer from the problem that the numbing agent is applied as a liquid pressurized spray. The liquid spray cannot be optimally atomized to adequately cool the skin. The liquid evaporates more slowly, thus reducing the cooling effect for a given amount of spray applied.
[0003] Another problem with injections is infection. Diabetics need to inject insulin at various intervals. This requires injections to be administered in less than optimal locations, which may not be entirely hygienic. When the needle or blade used to draw blood for testing is inserted, microorganisms can be pushed under the individual's dermis, causing infection or worse. Thus, there is a need for a numbing spray that also contains an antibacterial agent to reduce the incidence of infection. Summary of the Invention [Problem to be solved by the invention]
[0004] Currently, there is a need for a means to minimize the pain associated with injections. The present invention addresses this need by providing a syringe to which a liquid compressed gas canister is securely attached. The device contains an endothermic gas compressed into liquid form. When the liquid endothermic material is released, it is converted to steam and directed directionally to the injection point where it rapidly absorbs heat when released into the atmosphere. The endothermic steam is applied to the injection site prior to injection, minimizing the pain associated with conventional injection techniques. Additionally, the steam blanches the mucous membrane almost instantly, allowing the practitioner to easily identify the pre-treated injection site and ensuring that the needle is not inserted into an unanesthetized area. [Means for solving the problem]
[0005] An embodiment of the present invention is also directed to an apparatus including a syringe removably attached to a cold spray module for converting a liquefied gas to a vapor by impingement. The cold spray module is secured to a compressed gas assembly that holds a liquefied endothermic gas. The apparatus includes an actuation member for dispensing the contents of a container or canister that contains an anesthetic composition. The cold spray module includes an actuation member for controlled release of the liquefied endothermic gas for conversion to a vapor.
[0006] An embodiment of the present invention further relates to a liquefied endothermic gas canister assembly for attachment to the apparatus. The canister assembly includes a dispensing valve secured to a locking collar. The dispensing valve and locking collar combination prevents other types of pressurized canisters from being secured to the dispensing valve of the apparatus, thereby reducing or preventing use of the apparatus with unknown gaseous substances. The combination also prevents refilling of the gas cylinder with the wrong compressed gas.
[0007] Other embodiments are described below. [Brief description of the drawings]
[0008] [Figure 1] FIG. 1 is a perspective view of a cold spray assembly secured to a gas cylinder assembly and ready for use. [Diagram 2] FIG. 2 is a perspective view of the syringe module with the gas cylinder assembly removed. [Diagram 3] FIG. 2 is a perspective view showing a gas cylinder assembly with a syringe module connected thereto. [Figure 4] FIG. 2 is a partially exploded perspective view of an actuator portion of the gas cylinder assembly. [Diagram 5] 5 is a cross-sectional view of the actuator taken along line 5-5 of FIG. 4. [Figure 6A] FIG. 2 is a perspective view showing a core tube of a cold spray assembly that can be secured to the outer surface of a gas cylinder outlet tube. [Figure 6B] FIG. 1 is a perspective view showing a core tube of a cold spray assembly that can be secured to the inner surface of a gas cylinder outlet tube. [Figure 7A] FIG. 2 is a front view of the gas cylinder assembly. [Figure 7B] FIG. 7B is a side view of the gas cylinder assembly of FIG. 7A. [Figure 7C] FIG. 7C is a cross-sectional view taken along line 7C-7C of FIG. 7B. [Figure 7D]FIG. 7D is an enlarged partial cross-sectional view taken along line 7D-7D of FIG. 7C, illustrating a locking ring for providing a tamper-resistant gas cylinder assembly. [Figure 7E] FIG. 7B is a top view of the gas cylinder assembly of FIG. 7A. [Figure 7F] FIG. 2 is a partially exploded view showing the retaining ring of the gas cylinder assembly. [Figure 7G] FIG. 7B is a partial perspective view of the gas cylinder assembly of FIG. 7A. [Figure 8] FIG. 7B is an exploded view of the gas cylinder assembly shown in FIGS. 7A-7G. [Figure 9] 1 is an alternative embodiment of a gas cylinder assembly configured without a retaining ring. [Figure 10] FIG. 2 is a cross-sectional view of one embodiment of a cold spray assembly secured to a gas cylinder assembly. [Figure 11] FIG. 11 is an exploded view of the cold spray assembly of FIG. [Figure 12A] FIG. 2 is a perspective view of one embodiment of a core tube of a cold spray module. [Figure 12B] FIG. 12B is a side view of the core tube of FIG. 12A. [Figure 12C] FIG. 12B is a front view of the core tube of FIG. 12A. [Figure 12D] FIG. 12D is a cross-sectional view taken along line 12D-12D of FIG. 12C. [Figure 13A] FIG. 2 is a perspective view of a nozzle body of the cold spray module. [Figure 13B] FIG. 13B is a side view of the nozzle body of FIG. 13A. [Figure 13C] FIG. 13B is a front view of the nozzle body of FIG. 13A. [Figure 13D] FIG. 13D is a cross-sectional view taken along line 13D-13D of FIG. 13C. [Figure 14A] FIG. 2 is a front perspective view of an exploded nozzle of the cold spray module. [Figure 14B] FIG. 14B is a rear perspective view of the exploded nozzle of FIG. 14A. [Figure 14C] FIG. 14B is a side view of the exploded nozzle of FIG. 14A. [Figure 14D] FIG. 14B is a side view of the exploded nozzle of FIG. 14A. [Figure 14E] FIG. 14B is a front view of the exploded nozzle of FIG. 14A. [Figure 14F] FIG. 14B is a rear view of the exploded nozzle of FIG. 14A. [Figure 14G] 14G is a cross-sectional view of the exploded nozzle of FIG. 14A taken along line 14G-14G of FIG. 14C. [Figure 15] 1 shows the spray sequence for 80 / 20 SOLSTICE® Propellant: HFO-1234ze(E) and SOLSTICE® Enhance: HFO-1233zd(E) mixed with up to 10% PERIDEX® Chlorhexidine Gluconate 0.12%. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0009] While particular forms of the invention are illustrated, it should be understood that the invention is not limited to the specific forms or arrangements described and illustrated herein. It will be apparent to those skilled in the art that various modifications can be made without departing from the scope of the invention, and the invention should not be considered as limited to what is shown and described in this specification and the figures / figures contained herein.
[0010] With reference to Figures 1-15, an embodiment of the present invention relates to a method, agent, and device for applying an anesthetic agent, including an antimicrobial agent, in the form of a vaporized endothermic gas 29 (Figure 7C). An embodiment endothermic vapor applicator 100 can be attached to a syringe and provides endothermic vapor along a trajectory that coincides with the puncture point of an injection needle. This structure allows a user to align the device once with the skin 200, i.e., epidermis, dermis, where the endothermic gas vapor cools and numbs the skin, and then perform an injection without having to reposition the device. The endothermic vapor applicator 100 includes a cold spray module 10 and a canister assembly 12. The cold spray module 10 includes a cold spray module housing 16, a core tube 18, and a disassembled nozzle 20 that can be assembled to an outlet. The canister assembly 12 includes a canister 26, a valve assembly 28, and a retaining ring 30. In use, the syringe (not shown) includes a barrel, a plunger, a barrel tip, and a needle.
[0011] With reference to the drawings generally, and with reference to Figures 1-5 in particular, the endothermic vapor applicator 100 is shown as an assembly. In general, the cold spray module 10 is constructed and arranged to be removably attached to the canister assembly 12, and the cold spray module 10 and the syringe are removably attached to and connected together in an assembly such that the cold spray module 10 and the syringe can be operated with one hand. In this manner, the endothermic vapor applicator 100 can be aimed at the desired injection site and the endothermic gas (29) can be expelled, for example, with the thumb or index finger. The thumb can then be repositioned on the plunger of the syringe for injection. The endothermic gas vapor creates a blanched area on the skin 200 such that the area can be visualized and a needle or fingertip puncture can be performed in the numb area. The ergonomic construction of the endothermic vapor applicator 100 allows both operations to be performed without having to reposition the hand relative to the cold spray module 10 and the canister assembly 12, or vice versa. Thus, the disintegration nozzle 20 is constructed and arranged such that, when a syringe is attached to the cold spray module 10, endothermic vapor is directed as a flow that intersects the delivery axis of a needle connected to the syringe.
[0012] With reference to Figures 1-15, a cold spray module 10 is shown. The cold spray module 10 is typically connected, either permanently or removably, to a canister assembly 12 to maintain the position of each assembly relative to one another. Additionally, the cold spray module 10 directs liquefied endothermic gas from the canister assembly 12 to a desired area of the skin 200, breaking it down into a vapor stream as the liquid passes through the cold spray module 10. The cold spray module 10 includes a cold spray module housing 16 formed by a portion of a discharge tube 62, a core tube 18, and a breakup nozzle 20. The housing 16 is typically configured as a tubular section 40. The inner bore 50 of the tubular section 40 is typically a smooth, constant or slightly tapered bore and may include one or more internal flanges 52 for maintaining the position of the core tube 18 and breakup nozzle 20 within the inner bore. Thus, the core tube 18 shown in Figures 4-5 and 6A-6B is inserted into the inner bore 50 or outer diameter 51 of the tubular section 40. The core tube 18 receives the liquefied endothermic gas from the canister assembly 12 and provides a path for the liquid to travel as the liquid endothermic gas (29) impinges obliquely on the disintegration surface 54 of the disintegration nozzle 20, converting the liquid to vapor. The vapor expands and is expelled under pressure through the orifice, creating a stream of endothermic vapor that the user directs toward the skin surface 200. In at least some embodiments, as the plunger 34 is depressed, the siphon valve 53 opens, dispensing either the liquid endothermic gas or a combination of endothermic gas and antimicrobial solution simultaneously. Meanwhile, in some embodiments, the antimicrobial agent (27) (FIG. 7C) is denser than the endothermic gas 29 and therefore remains at the bottom of the canister 26. Opening the siphon valve 53 allows the endothermic gas to escape through the valve, creating a low pressure region within the dip tube, which draws the antimicrobial liquid into the endothermic gas stream and expels both simultaneously, thereby numbing and disinfecting the numbed area of the skin 200.
[0013] With reference to the drawings generally, and with reference to Figures 10-14G in particular, various embodiments of the core tube 18 are shown. In general, the core tube 18 is constructed and arranged to be in fluid communication with the canister assembly 12 to transport compressed liquid endothermic gas from the canister 26 and direct the liquid to the disintegration surface 54 of the disintegration nozzle 20. Thus, the core tube 18 can be provided in a variety of forms to provide the same or similar functions. Figures 10-11 and 13 show an embodiment of the core tube 18 including an elongated body 58 sized to fit within the tubular portion 40 of the cold spray module 10. A first end 60 of the core tube 18 is configured to fit within the discharge tube 62 of the canister valve 28. A second end 72 is configured to fit within the inner bore 68 of the disintegration nozzle 20. The snug fit between the parts allows the side 64 of the core tube 18 to include a U-shaped channel 70, whereby the inner surface 66 of the discharge tube 62, the inner bore 50 of the tubular portion 40 of the housing 16, and the inner bore 68 of the cracking nozzle 20 all form the closing surfaces of the U-shaped channel 70 and provide a passageway for the liquefied endothermic gas 29. The U-shaped channel 70 is located off-center in the core tube 18 and terminates in an annular groove 78 that directs the liquefied gas to the cracking surface 54 of the cracking nozzle 20. In this manner, the liquefied gas must impinge on the cracking surface 54 and traverse obliquely to reach the orifice 56 of the nozzle 20. FIGS. 12A-12D show another embodiment of the core tube 18. In this embodiment, the first end 60 of the tube is constructed and arranged to cooperate with the outer surface 51 of the discharge tube 62. In at least one embodiment, the discharge port 84 is configured by arranging a pair of offset flat panels 86 with a U-shaped notch 88 located in a central portion of the forward-most flat panel 86. The offset arrangement of the two panels 86 causes liquid to be discharged from the central conduit 80 at an angle relative to the longitudinal centerline of the core tube 18. In some embodiments, referring to FIG. 10 , a tapered sleeve 76 is overmolded or press-fit onto the outer surface of the tube 74 to fit snugly against the inner surface 66 of the discharge tube 62 of the canister assembly 12.It should be noted that the term "tight" does not require a liquid-tight or air-tight seal, as long as the majority of the liquid contacts the inner surface 66 of the discharge tube 62 and is transferred through the core tube 18 to the disintegration nozzle 20.
[0014] With reference generally to the drawings, and more particularly to FIGS. 2 and 3, the cold spray module 10 includes a syringe barrel securing assembly 90 that includes at least two opposing spring loaded clamping members 92 configured to secure a syringe barrel to the cold spray module 10. A spring or the like may be disposed in a pocket 102 disposed at the end of the clamping members 92 to bias the clamping members into a closed or clamped position. While a coil spring is preferred, it should be noted that other biasing members, such as elastomers, rubber, or torsion members, may be used without departing from the scope of the present invention. In a preferred embodiment, the spring is adjusted to hold a syringe of 1-3 cubic centimeters, although in other embodiments, the syringe may be sized to 15 cubic centimeters or larger.
[0015] Referring generally to the drawings, and more particularly to FIGS. 1, 3-5, 7A-9, an embodiment of a canister assembly 12 is shown. The canister assembly 12 includes a metal canister 26 having a valve assembly 28 crimped and sealed over an open end of the canister 26 to form a closed pressurized canister. Generally, the canister assembly 12 is configured and arranged to contain a liquefied endothermic gas 29 under sufficient pressure to maintain the gas in a liquid state until released from the canister 26. The valve assembly 28 includes a dispenser tube 114 extending outwardly therefrom for connection to the cold spray module 10 via a discharge tube 62 secured to a discharge actuator 116. The discharge actuator 116 is configured and arranged to be operated by depressing the dispenser tube 114 within the valve assembly 28, thereby allowing the liquefied endothermic gas to flow through the valve assembly 28 and the discharge tube 62. In one embodiment, when the valve assembly 28 is operated, the siphon valve 53 opens. The function of the siphon valve 53 is to allow the endothermic gas to be released from the valve 53 at the same or similar rate as the antimicrobial agent. In this way, the endothermic gas 29 numbs the desired area and the antimicrobial agent disinfects the numbed area. The antimicrobial agent is denser than the endothermic gas and therefore remains at the bottom of the canister 26. To release both materials, the siphon valve 53 opens and the endothermic gas is discharged through the release tube 62, creating a siphon effect in the dispenser tube 114, drawing the antimicrobial solution from the bottom of the canister 26 and dispensing both materials simultaneously from one container. In at least one embodiment, a retaining ring 30 is disposed under the valve assembly crimp used to attach the valve assembly 28 to the canister 26. The retaining ring 30 is laser or radio frequency welded 118 to the release actuator 116 to prevent the release actuator 116 from being removed from the canister 26. This construction prevents unnecessary refilling of the canister 26, which could allow contaminants or inappropriate liquids to enter the system.Removal of the release actuator 116 requires destruction of the locking ring 30, which is a clear indication of refilling or tampering with the canister 26. The cap 120 is constructed and arranged to cooperate with the release actuator 116 to prevent its inadvertent operation. Examples of liquefied endothermic gases that may be used include, but are not limited to, SOLSTICE® Propellant: HFO-1234ze(E) and / or SOLSTICE® Enhancer Gas: HFO-1233zd(E). These include PERIDEX® Chlorhexidine Gluconate 0.12% mixed with 10% or less as an antimicrobial agent. Chlorhexidine Gluconate is a 1,1 in a water-containing base. 1 It is made from hexamethylene bis[5-(p-chlorophenyl)biguanide]di-D-gluconate), 11.6% alcohol, glycerin, PEG-40 sorbitan diisostearate, flavor, sodium saccharin, and FD&C Blue No. 1. Peridex is a nearly neutral solution (pH range 5-7). Chlorhexidine gluconate is a salt of chlorhexidine and gluconic acid. It should be noted that other combinations of substances such as liquefied endothermic gases and antibacterial agents can be combined with the endothermic gas to provide antibacterial function while reducing the possibility of frostbite by lowering the temperature of the skin 200 to a level necessary to reduce the pain of the injection. On the other hand, it should be noted that the preferred mixture containing 10% or less of PERIDEX® Chlorhexidine Gluconate 0.12% as the antibacterial agent is not limited to this particular combination and may be any effective amount approved for use by physicians and medical professionals. It should also be noted that chlorhexidine gluconate is provided to be added to the refrigerant to increase the effective temperature of the refrigerant and inhibit skin frostbite. In this way, the refrigerant can be adjusted by using a larger amount of chlorhexidine gluconate to adjust the way the refrigerant lowers the skin temperature. The addition of chlorhexidine gluconate allows the refrigerant to partially act on the antibacterial agents in the warm air, thereby reducing the ability of the refrigerant to cool the skin.
[0016] 14A-14G, an embodiment of a disintegration nozzle 20 is shown. The disintegration nozzle 20 includes an aft disintegration face 54 and a front face 55 including a nozzle orifice 56. The aft disintegration face 54 includes at least one shear corner 134, and more preferably a plurality of shear corners 134. Generally, the shear corner 134 is an acute corner comprised of two adjacent planar faces 136, one of which is aligned parallel to the longitudinal centerline of the core tube 18 and one of which is disposed perpendicular to the core tube 18. In this manner, liquefied endothermic gas directed toward the aft disintegration face 54 impinges on the aft face 54 adjacent the nozzle orifice 56, and the liquid disintegrates and expands to exit the orifice 56 as a vapor having velocity. In a most preferred embodiment, the at least one shear corner 134 is an acute corner comprised of three adjacent planes 136 that define a U-shaped disintegration channel 138, two of which are aligned parallel to the longitudinal centerline of the core tube 18 and one of which is disposed perpendicular to the longitudinal centerline of the core tube 18. In another embodiment, the rear face 54 of the disintegration nozzle 20 includes four U-shaped disintegration channels 138. The disintegration channels 138 may be disposed at right angles to one another, dividing the rear face 54 into four quadrants. The core tube 18 is constructed and arranged to direct the liquefied endothermic gas to the rear disintegration face 54 at an acute angle to the longitudinal centerline of the core tube 18 in order to disintegrate the liquefied endothermic gas into vapor and direct it to the skin surface to appropriately reduce the skin temperature and cause skin numbness. The physical properties of the heat-absorbing endothermic vapor compress the blood flow of the skin 200 at the injection site, causing temporary numbness. The endothermic steam stops the propagation of painful nerve impulses and the patient feels touch or pressure rather than a pain sensation. According to the gate theory, pressure nerve fibers replace painful nerve fibers and mechanical contraction of muscles prevents the transmission of pain perception. The use of endothermic steam can also temporarily distract the patient by producing a noise that distracts the patient from potential or anticipated pain.Finally, the endothermic vapor blanches the mucosa, creating an easily visible target for needle insertion and ensuring that the numb area is not bypassed. Once the practitioner sees that the mucosa at the injection site has blanched and the site has been effectively numbed, a painless simultaneous injection can be performed. The practitioner can insert the injection needle and quickly inject into the injection site by depressing the release actuator 116. Due to the position of the disintegrating nozzle 20 relative to the needle, dispersion of the vapor and subsequent injection of the anesthetic agent can be accomplished nearly simultaneously, without pain to the patient.
[0017] 2-3, an embodiment of the present device is shown including a syringe barrel retaining assembly 90. The syringe barrel retaining assembly 90 includes a pair of finger grips 42. In some embodiments, a positioning anchor 44 extends from the area between the tubular portion 40 and the syringe barrel retaining assembly 90 and snaps onto an upper rim 46 of the valve assembly 28 to prevent rotational and linear movement between the canister assembly 12 and the cold spray module 10. A second finger grip 48 may be integrally formed into the tubular portion 40 to provide versatility for gripping the endothermic vapor applicator 100.
[0018] Those skilled in the art will readily appreciate that the present invention is well adapted to carry out the objects and attain the objects and advantages mentioned, as well as those inherent therein. The embodiments, methods, procedures, and techniques described herein are presently representative of preferred embodiments, and are intended to be illustrative, not limiting in scope. Those skilled in the art will recognize modifications thereof and other uses which are within the spirit of the invention and are defined by the scope of the appended claims. Although the invention has been described in connection with certain preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention which are obvious to those skilled in the art are intended to be included within the scope of the following claims.
Claims
1. An endothermic vapor applicator (100), comprising: a canister assembly (12) containing a liquefied endothermic gas (29); The canister assembly (12) is fluidly connected to a cold spray module (10), and the liquefied endothermic gas is broken down into droplets prior to being discharged from the cold spray module (10); The canister assembly (12) contains an antimicrobial liquid mixed with the endothermic gas within a canister (26); the liquefied endothermic gas (29) entrains the antimicrobial liquid (27) within the liquefied endothermic gas (29) as it is discharged from the canister (26); said liquefied endothermic gas (29) constructed and arranged to be at a suitable temperature to cause paralysis without causing frostbite when directed at human skin (200); The endothermic steam applicator is characterized in that the antibacterial liquid (27) disinfects the numb area.
2. The endothermic vapor applicator (100) of claim 1, wherein the liquefied endothermic gas (29) is HFO-1234ze(E).
3. 3. The endothermic vapor applicator (100) of claim 2, wherein the antimicrobial liquid (27) is chlorhexidine gluconate.
4. 3. The endothermic vapor applicator (100) of claim 2, wherein the antimicrobial liquid (27) is chlorhexidine gluconate 0.12%.
5. The endothermic vapor applicator (100) of claim 1, wherein the endothermic gas (29) is HFO-1233zd(E).
6. 6. The endothermic vapor applicator (100) of claim 5, wherein the antimicrobial liquid (27) is chlorhexidine gluconate.
7. 6. The endothermic vapor applicator (100) of claim 5, wherein the antimicrobial liquid (27) is chlorhexidine gluconate 0.12%.
8. 2. The endothermic vapor applicator (100) of claim 1, wherein the endothermic gas (29) is a combination of HFO-1234ze(E) and HFO-1233zd(E).
9. 9. The endothermic vapor applicator (100) of claim 8, wherein the antimicrobial liquid (27) is chlorhexidine gluconate.
10. 9. The endothermic vapor applicator (100) of claim 8, wherein the antimicrobial liquid (27) is chlorhexidine gluconate 0.12%.
11. 2. The endothermic vapor applicator (100) of claim 1, comprising: The canister assembly (12) includes a cold spray module (10); the cold spray module (10) includes a core tube (18) that impinges the liquefied endothermic liquid (29) against a cracking surface (54) to crack the liquid stream into endothermic vapors, and then passes the endothermic vapors through a cracking nozzle (20); 13. An endothermic vapor applicator, comprising: a cracking nozzle (20) constructed and arranged to direct endothermic vapor as a stream.
12. 2. The endothermic vapor applicator (100) of claim 1, comprising: The canister (26) is a metal canister having a valve assembly (28) crimped and sealed within an open end of the canister (26) to form a closed pressurized canister; The valve assembly (28) includes a discharge tube (62) extending outwardly therefrom for connection to the cold spray module (10).
13. 13. The endothermic vapor applicator (100) of claim 12, wherein the valve assembly (28) is finger operable to release the liquefied endothermic gas (29).
14. 2. The endothermic vapor applicator (100) of claim 1, comprising: The decomposition surface (54) is the rear surface of the decomposition nozzle (20); The liquefied endothermic gas (29) is directed toward the decomposition surface (54) and impinges on the decomposition surface (54) adjacent a nozzle orifice (56), and the liquefied endothermic gas (29) decomposes, expands, and is emitted from the nozzle orifice (56) with a velocity.
15. 15. The endothermic steam applicator (100) of claim 14, wherein the disintegrating surface (54) of the disintegrating nozzle (20) includes at least one shear corner (134).
16. 15. The endothermic steam applicator of claim 14, wherein the disintegrating surface of the disintegrating nozzle includes a plurality of shear corners.
17. 15. The endothermic vapor applicator (100) of claim 14, comprising: the at least one shear corner (134) is a sharp corner formed by two adjacent planar surfaces (136); one of said planes (136) is oriented parallel to the longitudinal centerline of the core tube (18); An endothermic vapor applicator, wherein one of said planar surfaces (136) is disposed perpendicular to said core tube (18).
18. 15. The endothermic vapor applicator (100) of claim 14, comprising: the at least one shear corner (134) being a pair of sharp corners formed from three adjacent planar surfaces (136) that define the U-shaped channel (70); Two of said planes (136) are aligned parallel to the longitudinal centerline of the core tube (18); An endothermic vapor applicator, wherein one of said planar surfaces (136) is disposed perpendicular to said core tube (18).
19. 15. The endothermic steam applicator (100) of claim 14, wherein a core tube (18) is constructed and arranged to direct the liquefied endothermic gas (29) to the decomposition surface (54) of the decomposition nozzle (20) at an acute angle relative to a longitudinal centerline of the core tube (18).
20. 15. The endothermic vapor applicator (100) of claim 14, comprising: The endothermic vapor applicator is characterized in that a discharge actuator (116) is constructed and arranged to be actuated by depressing a dispenser tube (114) in a valve assembly (28), thereby causing the liquefied endothermic gas to flow through the valve assembly (28) and the discharge tube (62).
21. 21. The endothermic vapor applicator (100) of claim 20, comprising: When the valve assembly (28) is actuated, the siphon valve (53) opens, The siphon valve (53) allows the endothermic gas to be released through the valve (53) at the same or similar rate as the antimicrobial agent; The antimicrobial agent is denser than the endothermic gas and is drawn through a dispenser tube (114) and 2. An endothermic vapor applicator comprising: a) a first endothermic vapor applicator configured to: (a) pass through said siphon valve (53) and (b) discharge both materials through said discharge tube (62).
